Abstract
We identified two additional mutations in the ferrochelatase gene in two Swiss patients with erythropoietic protoporphyria (EPP). Ferrochelatase cDNA from patients was amplified by the polymerase chain reaction (PCR) and subjected to mutation analysis by sequencing PCR products either directly or after subcloning. The first patient, who underwent liver transplantation because of terminal liver failure, was identified as having a single point mutation (C to T) at nucleotide 175 that resulted in a Gln to stop codon conversion in one allele of the gene. In the second case, in which the patient has so far no liver involvement, a two-base deletion (T899G900) was found in one allele. Frameshift as a result of the deletion creates a stop codon. This study presents two new genotypes of EPP, including one with liver failure, a rare and fatal form of EPP.
This is a preview of subscription content, log in via an institution to check access.
References
Brenner D, Didier J, Frasier F, Christensen S, Evans G, Dailey H (1992) A molecular defect in human protoporphyria. Am J Hum Genet 50:1203–1210.
Guo R, Lim C, Peters T (1991) High-performance liquid chromatography assays for protoporphyrinogen oxidase and ferrochelatase in human leucocytes. J Chromatogr 566:383–396.
Lamoril J, Boulechfar S, Verneuil H de, Grandchamp B, Nordmann Y, Deybach J (1991) Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun 181:594–599.
Nakahashi Y, Taketani S, Okuda M, Onoue K, Tolunaga R (1990) Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase. Biochem Biophys Res Commun 173:748–755.
Nakahashi Y, Fujita H, Taketani S, Ishida N, Kappas A, Sassa S (1992) The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria. Proc Natl Acad Sci USA 89:281–285.
Nakahashi Y, Miyazaki H, Kadota Y, Naitoh Y, Inoue K, Yamamoto M, Hayashi N, Taketani S (1993a) Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene. Hum Mol Genet 2:1069–1070.
Nakahashi Y, Miyazaki H, Kadota Y, Naitoh Y, Inoue K, Yamamoto M, Hayashi N, Taketani S (1993b) Molecular defect in human erythropoietic protoporphyria with fatal liver failure. Hum Genet 91:303–306.
Rossi E, Costin A, Garcia-Webb P (1988) Ferrochelatase activity in human lymphocytes, as quantified by new high-performance liquid chromatography method. Clin Chem 34:2481–2485.
Schleiffenbaum B, Minder EI, Möhr P, Decurtis M, Schaffner A (1992) Cytoflourometry as a diagnosis of protoporphyria. Gastroenterology 102:1044–1048.
Wang X, Poh-Fitzpatrick M, Carriero D, Ostasiewicz L, Chen T, Taketani S, Piomelli S (1993) A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing. Biochim Biophys Acta 1181:198–200.
Went L, Klase E (1984) Genetic aspects of erythropietic protoporphyria. Ann Hum Genet 48:105–117.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider-Yin, X., Schäfer, B.W., Möhr, P. et al. Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet 93, 711–713 (1994). https://doi.org/10.1007/BF00201578
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00201578